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Effects of Alcohol and 

HIV Infection on the 

Central Nervous System

Dieter J. Meyerhoff, Ph.D. 
Many people at risk for or infected with the human immunodeficiency virus (HIV) are heavy 
drinkers. Both HIV infection and heavy alcohol use adversely affect the immune system and 
central nervous system (CNS) function. However, little research has addressed the effects of 
heavy alcohol use on the severity and progression of HIV disease, including the development of 
HIV-associated CNS disease. Animal and in-vitro studies suggest that alcohol impairs various 
aspects of the immune system and increases the susceptibility to HIV infection, but may not 
accelerate progression of HIV disease. However, heavy alcohol use may interfere with the 
patient’s adherence to antiretroviral treatment regimens. Neuropathological and 
neuropsychological studies have indicated that certain brain areas are affected by both HIV-
infection and chronic alcohol abuse. Magnetic resonance spectroscopy studies of both HIV-
positive and HIV-negative people who were either heavy or light drinkers found that chronic 
alcohol abuse exacerbates some metabolic injury in the brains of HIV-infected people, although 
this effect may be less pronounced in patients receiving effective antiretroviral therapy. KEY WORDS: 
HIV infection; central nervous system; immune system; heavy AOD (alcohol and other drug) use; 
chronic AODE (effects of AOD use, abuse, and dependence); drug therapy; patient compliance; 
brain damage; neuropathy 
Infection with the human immuno­deficiency virus (HIV) and the result­ing acquired immunodeficiency syn­
drome (AIDS) epidemic are major public 
health problems in the United States 
and worldwide. One common cause of 
illness and death associated with HIV 
infection is central nervous system (CNS) 
disease. The most severe manifestation 
of CNS disease is HIV-associated demen­
tia complex (HADC), a neurological 
syndrome characterized by disordered 
mental functions (i.e., cognition), motor 
functions, and behavior. Many members 
of populations at high risk for HIV 
infection (e.g., intravenous drug users 
and homosexuals) also are heavy drinkers, 
and alcohol has its own adverse effects 
on CNS function. Nevertheless, almost 
no research has directly addressed the 
effects of heavy alcohol use on the 
severity of HIV disease and its progres­
sion to AIDS. 
This review summarizes information 
regarding the prevalence of alcohol abuse 
among HIV-infected people as well as 
current knowledge regarding the separate 
and combined effects of HIV infection 
and alcohol use on the brain and the 
immune system. The article then reviews 
the relationship among alcohol use, 
adherence to HIV treatment regimens, 
and HIV disease progression. Sub­
sequently, it discusses the CNS effects 
of HIV infection/AIDS and alcohol 
abuse, focusing on pathological and 
psychological observations as well as on 
findings obtained using various imaging 
techniques. Finally, the article reviews 
the scant published literature on the 
CNS effects of combined HIV infection 
and alcohol abuse. 
DIETER J. MEYERHOFF, PH.D., is an 
associate professor in the Department 
of Radiology and Department of 
Veterans’ Affairs Medical Center, 
University of California San Francisco, 
San Francisco, California. 
Support for this work was provided by 
National Institute on Alcohol Abuse and 
Alcoholism grants RO1–AA–10788 and 
PO1–AA–11493. 
288 Alcohol Research & Health 
Alcohol and HIV Infection 
Prevalence of Chronic 
Alcohol Use Among the 
HIV-Infected Population 
By the end of the year 2000, approxi­
mately 920,000 Americans were living 
with HIV infection/AIDS,1 and approx­
imately one-half of these patients had 
been infected with HIV for more than 
10 years. Most HIV-infected people in 
North America are between ages 18 to 
44. Within the general American pop­
ulation of this age range, 17 percent 
of men and 10 percent of women are 
afflicted at some point over their lifespan 
by an alcohol use disorder (AUD)—that 
is, alcohol abuse or dependence. Among 
alcohol-abusing patients, the HIV infec­
tion rate is significantly higher than for 
the general population—that is, about 
5 to 10 percent (depending on risk factors 
such as intravenous drug use, homosex­
uality, and geographic location). (For a 
more extensive review of alcohol use in 
HIV-infected patients see, for example, 
Petry 1999.) 
Similarly, AUDs are much more 
common among HIV-infected people 
than among the general U.S. population. 
For example, 29 to 60 percent of HIV-
infected patients develop an AUD at 
some point during their lives, a rate that 
is approximately three times as high 
as that of the general U.S. population. 
In fact, this prevalence rate is one of 
the highest rates of drug abuse found 
among any population group in the 
United States. Moreover, the prevalence 
of a current AUD among HIV-infected 
patients is nearly 12 percent, about 
twice the rate of the general population 
(Petry 1999). 
Some researchers have questioned 
these statistics because of a purported 
sampling bias. Most of this epidemio­
logical work was conducted during the 
early phase of the HIV/AIDS epidemic 
in the mid 1980s and included almost 
entirely samples of gay men who were 
not representative of the HIV-infected 
community as a whole (e.g., the partic­
ipants were recruited in gay bars) (see 
Paul et al. 1991). Therefore, the actual 
1With the total U.S. population at approximately 270 
million, this corresponds to approximately 0.35 percent of 
the total population. 
AUD prevalence rates may be lower 
than these early estimates. Nevertheless, 
a large proportion of HIV-infected 
people likely is abusing alcohol or is 
“alcoholic.”2 Between 1984 and 1992 
(the latest time period for which such 
data are available), however, the abuse 
rates for both alcohol and other drugs 
(with the exception of amphetamines) 
declined among HIV-infected people, 
either as a result of aging among HIV-
infected men or as a reaction to the ongo­
ing AIDS epidemic (Crosby et al. 1998). 
Research into the added risk associ­
ated with the presence of an AUD on 
HIV infection rates and on disease pro­
gression to AIDS and HADC is only 
in its infancy. AUDs may affect HIV-
associated CNS disease in two ways. 
First, heavy chronic drinking may has-
ten the progression of the overall HIV 
disease process through biological (e.g., 
immunological) effects. Second, AUDs 
may interfere with treatment seeking, 
treatment adherence, and treatment 
effectiveness among HIV-infected people. 
The following sections briefly summa­
rize these effects separately for HIV/AIDS 
and AUDs as well as for the co-occurrence 
of both diseases. 
Biological and 
Immunological Effects 
of HIV Infection and 
Chronic Alcohol Use 
Targets of HIV Infection in the 
Immune System and CNS 
The primary target of HIV in the body 
is a type of immune cell called the CD4+, 
or T-helper cell,3 which plays a pivotal 
role in the body’s defense against disease-
causing microorganisms (i.e., pathogens). 
HIV-infected CD4+ cells produce new 
virus and eventually die. As a result, the 
infected person’s levels of CD4+ cells in 
the blood slowly decline, leaving him or 
her increasingly vulnerable to infections 
by various pathogens that normally are 
controlled easily by the immune system 
(i.e., opportunistic infections) and to 
unusual cancers. 
CD4+ cells are not found in the brain, 
however, and HIV therefore must infect 
other cells there to cause CNS disease. 
The primary cell types in the CNS are 
nerve cells (i.e., neurons) and glial cells, 
which include the following three 
major subtypes: 
•	 Astrocytes, which provide structural 
and functional support for neurons 
and which are important for the 
regulation of ion concentrations 
•	 Oligodendrocytes, which extend 
projections that form a protective 
sheath (i.e., myelin sheath) around 
the extensions (i.e., axons) of neurons 
•	 Microglia, which can change into a 
type of immune cell called phago­
cyte or macrophage that seeks out 
and destroys foreign microorgan­
isms and viruses. 
HIV does not infect neurons, but it 
does infect microglia and, to a lesser 
extent, astrocytes. Once HIV has entered 
the brain, these “activated” microglia 
and multiplying astrocytes produce 
increasing amounts of substances that 
when present at excessive levels are 
toxic to neurons (i.e., neurotoxins). 
The production of neurotoxins is stim­
ulated by compounds called cytokines 
that act as chemical messengers among 
immune cells as well as between immune 
and nonimmune cells. The same cyto­
kines also further enhance the multipli­
cation of astrocytes and microglia (i.e., 
gliosis) as well as the production of new 
HIV particles. 
Neurotoxins can damage or even kill 
neurons, and this process is thought to 
contribute to the neuropsychological 
and cognitive deterioration that occurs 
during the natural course of HIV dis­
ease. The most serious consequence of 
this deterioration is HADC, which is 
found in approximately 15 percent of 
HIV-infected people, mostly in those 
patients whose immune systems have 
already been severely damaged by 
2Terms such as “chronic alcohol use,” “alcohol abuse,” 
“alcoholism,” “heavy drinking,” and similar terms have 
variable definitions in the literature. Therefore, these terms 
are used here as in the original studies and reviews cited. 
3For a definition of this and other technical terms used in 
this article, see the glossary, p. 297. 
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HIV (i.e., patients who are severely 
immunosuppressed4). 
Effects of Alcohol on the 
Immune System 
Chronic heavy alcohol use is associated 
with increased illness and even death 
related to infectious diseases, although 
alcohol’s specific effect on the immune 
system in these relationships is contro­
versial. Limited studies conducted in 
intact animals (i.e., in vivo) and in cul­
tured tissues and cells (i.e., in vitro) 
suggest that alcohol can interfere with 
the normal functions of various com­
ponents of the immune system (e.g., 
natural killer cells and T-cells), thereby 
impairing the body’s response to path­
ogens (for a review, see Szabo 1999). 
However, little is known about the 
effects that acute and chronic alcohol 
consumption have on the function of 
the peripheral (i.e., not pertaining to 
the CNS) immune system in humans, 
and no information exists about alcohol’s 
Petry 1999). Therefore, researchers have 
postulated that chronic alcohol use by 
HIV-positive people may exacerbate 
the immunological abnormalities that 
are associated with HIV infection. 
Researchers have begun to analyze the 
effects of alcohol in HIV-infected sub­
jects using rodent models of HIV 
infection, in which mice are infected 
bility of human cells to HIV infection. 
Alcohol may exert these effects either 
directly, by acting on CD4+ cells, or 
indirectly, by altering the production of 
cytokines. Some of these effects may be 
reversible, however, because studies on 
alcoholic HIV-infected patients under-
going alcoholism treatment found that 
the patients’ levels of CD4+ cells improved 
after detoxification (Pol et al. 1996). 
Although it appears likely that alcohol 
impairs the activity of the peripheral 
immune system and increases the sus­
ceptibility to HIV infection, the effects 
of alcohol on human immune function 
in the CNS and on the susceptibility of 
brain cells to HIV infection are ambigu­
ous. Similarly, the impact of alcohol 
use on the progression of HIV disease 
to AIDS remains unclear. Several 
immunological studies followed large 
numbers of alcohol-consuming homo-
sexual men over time but found no evi­
dence that alcohol accelerated disease 
progression to AIDS (e.g., Kaslow et al. 
1989; Penkower et al. 1995). These stud-
effects on the immune function of the 
CNS (i.e., on the microglia). Animal 
and human studies suggest that chronic 
alcohol consumption adversely affects 
the peripheral immune system, probably 
by inducing the production of cytokines. 
If a similar mechanism exists in the 
CNS, alcohol-induced cytokine release 
could increase the amount and activity 
of neurotoxins and, subsequently, lead 
to the death of neurons. This hypothe­
sis of alcohol-induced neuron damage 
is consistent with the findings of neu­
ropathological and imaging studies of 
chronic alcohol abusers. 
Effects of Combined HIV 
Infection and Alcohol Use 
on the Immune System 
The previous two sections suggest that 
both HIV infection and chronic heavy 
drinking have similar and profound effects 
on the immune system (for extensive 
reviews, including immunological and 
behavioral concepts, see Dingle and 
Oei 1997; Tyor and Middaugh 1999; 
4Severe immunosuppression is defined as having less than 
200 CD4+ cells per cubic millimeter (mm3) of blood; normal 
levels of CD4+ cells are approximately 1000 cells/mm3. 
with a virus that is similar to HIV and 
can develop a condition comparable to 
AIDS. These studies suggest that both 
acute and chronic alcohol consumption 
reduce the animals’ peripheral immune 
functions, possibly by altering the release 
of certain cytokines (for reviews, see Tyor 
and Middaugh 1999; Dingle and Oei 
1997). Furthermore, the animals progress 
more rapidly from the initial viral infec­
tion to mouse-type AIDS or death. 
Researchers also have conducted 
studies using immune cells (i.e., lym­
phocytes)—including CD4+ cells— 
that were isolated from healthy, non-
HIV-infected human subjects both 
before and after the subjects consumed 
3 to 9 alcoholic drinks over 2 days 
(Bagasra et al. 1993). The studies sug­
gested that alcohol consumption dam-
aged the peripheral immune system, 
because when the isolated cells were 
infected with HIV in a test tube, the virus 
multiplied faster in cells taken after 
alcohol consumption. Furthermore, 
cells isolated after alcohol consumption 
exhibited reduced CD4+ functions 
compared with cells isolated before alco­
hol consumption. These findings sug­
gest that alcohol increases the suscepti­
ies have methodological weaknesses, 
however. For example, one study fol­
lowed the participants only over a period 
of 18 months, which may not have 
been long enough, considering that it 
usually takes approximately 3 to 10 years 
for an HIV-infected person to develop 
AIDS. Another study only examined 
the effects of consumption of up to 
approximately 70 alcohol-containing 
drinks per month, or a little more than 
2 drinks per day, which generally is 
considered moderate drinking; the study 
did not assess the consequences of 
heavier drinking. A more recent report 
suggests, however, that even heavy 
drinking (i.e., more than 150 drinks 
per month for an unspecified duration) 
does not significantly alter the effective­
ness of antiretroviral treatment in con-
trolling the virus levels in HIV-infected 
patients (Fabris et al. 2000). This finding 
also implies that alcohol consumption 
does not accelerate the progression of 
HIV disease. 
In summary, animal and in-vitro stud­
ies have indicated that chronic alcohol 
use can have deleterious effects on the 
immune system. In addition, chronic 
alcohol use may influence a person’s 
susceptibility to infections by modifying 
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chronic alcohol 
use can have 
deleterious effects 
on the immune 
system. 
Alcohol and HIV Infection 
the nutritional status and promoting the 
generation of highly reactive molecules 
that can damage the cells (i.e., oxidative 
stress) (see Wang and Watson 1995). 
Thus, it appears plausible that heavy 
drinking would increase a person’s sus­
ceptibility to infection by HIV and 
accelerate disease progression to AIDS. 
To date, however, no strong immuno­
logical evidence links chronic alcohol 
consumption at any level to an accelerated 
course of HIV disease. The paucity of 
existing immunological data demon­
strates a great need for well-controlled, 
preferably long-term studies to document 
the combined effects of HIV infection 
and heavy alcohol consumption on the 
progression of HIV disease in this era 
of promising antiretroviral therapy. 
Adherence to HIV Treatment 
The currently recommended treatment 
for patients with HIV infection frequently 
involves therapy with three different 
medications from two classes of medica­
tions called reverse transcriptase inhibitors 
and protease inhibitors.5 This treat­
ment regimen, which is called highly 
active antiretroviral therapy (HAART) 
or potent antiretroviral therapy, can 
reduce the patient’s risk of opportunistic 
infections commonly associated with 
HIV infection and HADC, as well as 
improve mental abilities and survival 
rates. The three medications must be 
administered according to very strict 
schedules requiring the patient to take 
more than a dozen tablets at specific 
times each day, some of them with a 
meal and others without food. For this 
treatment to be most effective, the patients 
must adhere to the schedule approxi­
mately 95 percent of the time. Such 
a regimen requires a level of discipline 
that many patients cannot maintain. 
Thus, studies among outpatients indicate 
that about one-half of HIV-infected 
patients skip drug doses or pills for a 
variety of reasons—wanting to avoid 
side effects associated with the medica­
tions, having experienced a change in 
their daily routines, being busy with 
other things, being away from home, 
forgetting, or being depressed. Other 
factors, such as HIV-associated memory 
impairment or compromised health, also 
may reduce a patient’s adherence to the 
treatment schedule. By not adhering to 
the complex treatment regimen, patients 
may not only limit treatment effective­
ness but may increase the risk that a 
treatment-resistant virus develops because 
the medication levels are too low. 
Studies have indicated that HIV-
infected patients who use illicit drugs 
are less willing to begin antiretroviral 
treatment and have greater difficulty in 
adhering to a treatment regimen com­
pared with patients who do not use 
drugs (see Petry 1999). These findings 
suggest that alcohol-abusing HIV-infected 
patients also exhibit lower adherence to 
their treatment regimens than do non-
alcohol-abusing patients. Furthermore, 
because the patients in the existing stud­
ies were only taking a single medication, 
it is reasonable to assume that adherence 
to the more complex HAART regimen 
is even lower. Although this issue has 
not yet been studied, it is likely that 
nonadherence to antiretroviral treatment 
is an important factor in the relation-
ship between alcohol abuse and HIV 
disease progression, including the 
development of psychiatric symptoms 
and mental impairment. 
An example of this problem can be 
found among the tuberculosis popula­
tion. In tuberculosis patients with alcohol 
or other drug abuse problems, nonad­
herence to treatment medication has 
led to the emergence of medication-
resistant strains, the frequency of which 
only decreased with directly observed 
antituberculosis therapy. 
Effects of HIV 
Infection and Alcohol 
Abuse on the CNS 
The development of new antiretroviral 
medications has greatly enhanced treat­
ment effectiveness in controlling the 
spread of HIV in the body. These med­
ications cannot effectively enter the CNS, 
however, to eradicate the virus that has 
infected brain cells. Accordingly, factors 
that influence CNS disease, such as 
alcohol abuse, may become even more 
important in the clinical management 
of HIV disease and of the HIV epidemic. 
The separate effects of HIV infection 
and chronic alcohol abuse on brain 
structure and function and on biologically 
relevant molecules that are associated 
with neuron loss and gliosis are well 
established. However, almost no research 
has addressed directly the effect of heavy 
alcohol use on the severity and progres­
sion of HIV-associated CNS disease. 
This section reviews the main CNS 
effects of both HIV infection and alcohol 
abuse by summarizing the pathological 
and psychological evidence for brain 
damage associated with both conditions. 
This discussion also describes structural 
and some functional correlates of such 
damage, which can help to understand 
the cognitive changes occurring in 
alcohol-abusing HIV-infected patients. 
Neuropathology and Neuropsychology 
of HIV-Infected People 
Neuropathological studies6 conducted 
during the 1990s found that approxi­
mately 75 percent of the AIDS patients 
studied exhibited some kind of CNS 
damage. Furthermore, a similar propor­
tion of AIDS patients exhibited neuro­
logical signs or symptoms before their 
death, such as memory loss, decreased 
concentration and attention, and prob­
lems with movement or balance (Price 
1999). Neuropathological studies also 
revealed virus-associated abnormalities 
in various brain areas, including the 
following (Price et al. 1988; Cummings 
1986) (see figure): 
•	 The basal ganglia. These are groups 
of nerve cells located deep inside the 
brain that help control motor and 
cognitive activity. The basal ganglia 
region carries the heaviest HIV load 
of all brain structures and shows 
effects of gliosis and inflammation 
early in the course of the disease. 
Neuron loss in this region, although 
it is not a common finding, has 
been reported in some more recent 
studies (Masliah et al. 1996). 
5These medications derive their names from the fact that 
they inhibit the functions of two important viral enzymes 
called reverse transcriptase and protease. 
6Neuropathological studies assess structural brain damage 
by directly examining brain tissue (e.g., in autopsy studies). 
Neuropsychological studies evaluate behavioral and 
cognitive deficits and other psychological symptoms. 
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•	 White matter around the fluid-filled 
spaces (i.e., ventricles) in the brain. 
White matter consists primarily of 
glial cells and axons surrounded by 
myelin sheaths. In HIV-infected 
patients, this white matter is infil­
trated by various immune cells (i.e., 
macrophages and lymphocytes). 
Patients with advanced stages of HIV 
disease often exhibit abnormal pro­
liferation of glial cells and changes in 
the myelin sheaths. 
•	 The cortex. The cortex is the brain’s 
outer layer, which is responsible for 
higher cognitive functions. In advanced 
stages of AIDS, cortical changes have 
been reported, including loss of large 
motor neurons, decreased density of 
the neuron structures that allow nerve 
signal transmission among neurons 
(i.e., synapses), and damaged neuronal 
extensions (i.e., dendrites) that nor­
mally receive incoming nerve signals. 
Consistent with these observed abnor­
malities, HADC patients in neuropsy­
chological studies exhibit a constellation 
of deficits associated with dementia 
resulting from damage to brain regions 
other than the cortex (i.e., subcortical 
dementia), including deficits in concen­
tration and attention, psychomotor 
slowing, and mild-to-moderate impair­
ments of memory and abstraction ability 
(Cummings 1986). Similar impairments 
are sometimes observed in alcoholic 
patients. Even though many HIV-infected 
people are heavy drinkers, a study com­
paring the neuropsychological functions 
of HIV-positive and HIV-negative par­
ticipants suggested that alcohol use did 
not account for differences in the test 
scores between the two groups (Bornstein 
et al. 1993). HAART has been shown 
to improve neuropsychological test 
performance of HIV-infected people in 
some but not all cognitive domains 
(Tozzi et al. 1999). 
Brain Structure and Metabolites 
in HIV-Infected People 
Researchers have used various imaging 
techniques, including magnetic resonance 
imaging (MRI) to analyze changes in 
the brain structure of HIV-infected 
people and magnetic resonance spec­
troscopy (MRS) to measure brain chem­
icals. For both of these techniques, the 
patient is exposed to radiowaves in the 
presence of a powerful magnetic field. 
This treatment causes the nuclei of hydro­
gen atoms in the water and chemicals 
of the different brain tissues to emit 
signals, depending on their location 
within the brain and their local surround­
ings. MR computers translate these 
signals into two- or three-dimensional 
images that delineate specific structures 
(e.g., various brain regions) or into spectra 
that show characteristic peaks for spe­
cific chemicals. MRI and MRS differ 
in the kind of signal they detect: MRI 
measures mainly water and, to a lesser 
extent, fatty substances (i.e., lipids), 
whereas MRS detects signals from amino 
acids (which are the building blocks of 
proteins), building blocks and breakdown 
products of lipids, and certain molecules 
involved in energy production. Thus, 
MRS can detect abnormalities of metabo­
lites in specific brain regions, whereas 
MRI can detect structural brain abnor­
malities and can differentiate with great 
accuracy (i.e., at high spatial resolution) 
white matter tissue in the brain from 
gray matter tissue (which consists pri­
marily of neuronal cell bodies and den­
drites). MRI also can detect changes 
Location of brain areas affected by HIV infection and/or alcohol use. Panel A represents a lengthwise cut through the brain, with the 
front of the brain facing right. Panel B represents a horizontal (i.e., axial) cut through the brain, with the front of the brain facing up. 
* Part of the basal ganglia. 
Parietal lobe 
Cerebral cortex 
Frontal lobe 
Frontal lobe 
Cortical gray 
matter 
Frontal lobe 
White matter 
Lenticular nucleus* 
(globus pallidus, putamen) 
Cerebellum 
Brain stem 
Temporal lobe 
Thalamus 
Caudate* 
Lateral 
ventricle 
B A 
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in the volumes of both types of tissue. 
Combined, these two techniques allow 
a powerful and noninvasive view inside 
the brain. (For a description of MRS 
and the molecules it measures, see the 
sidebar on p. 294). 
MRI studies of HIV-positive patients 
who show no symptoms of HIV disease 
and no dementia (i.e., patients who are 
asymptomatic) reveal generally mild brain 
on routine MRI. Several studies found 
that HIV-infected patients with cogni­
tive impairments had lower NAA levels 
in white and gray matter than did those 
without cognitive impairments or HIV-
negative control subjects, suggesting 
neuronal and/or axonal damage in the 
impaired patients. The NAA changes 
were largest in white matter of the frontal 
therapy on the CNS. Changes were 
observed in repeated MRS studies of 
patients who received several months of 
antiretrovial therapy; those patients demon­
strated a partial reversal of the metabolic 
abnormalities (Chang et al. 1999). 
Neuropathology and Neuropsychology 
of Chronic Alcohol Abusers 
shrinkage (i.e., atrophy) compared with 
HIV-negative people (for a review see, 
for example, Navia and Gonzalez 1997). 
Patients with HADC and/or advanced 
stages of HIV disease, however, generally 
exhibit greater brain atrophy affecting 
many brain areas. Consistent with the 
neuropathological studies described in 
the previous section, symptomatic HIV-
positive patients in MRI studies showed 
loss of brain volume particularly in white 
matter, temporal lobe gray matter, the 
basal ganglia, and the posterior cortex. 
In particular, shrinkage of the caudate— 
a small structure in the basal ganglia 
related to cognition and motivation that 
is connected to the prefrontal cortex— 
appears to be associated with dementia 
and advanced disease stage. 
Although MRI studies can be useful 
in a research setting, the findings are not 
sensitive enough and not specific for 
HIV disease in a clinical setting. In other 
words, MRI might miss some HIV-
related changes in brain structure or 
the observed changes might result from 
other conditions. In general, MRI studies 
have not been shown to be useful in 
documenting the degree and progression 
of HIV-related CNS disease. Moreover, 
it is still too early after the introduction 
of potent antiretroviral medications to 
state conclusively how well HAART has 
affected the frequency and degree of 
HIV-related brain abnormalities (other 
than opportunistic infections of the CNS) 
detectable by MRI. 
MRS may be more sensitive than 
MRI in detecting neurological changes 
in HIV/AIDS patients (for a review see 
Navia and Gonzalez 1997). For example, 
researchers have measured the levels of 
a molecule called N-acetyl-aspartate 
(NAA), which serves as an indicator 
of neuron viability. In those studies, 
researchers noted changes in NAA levels 
in brain regions that appeared normal 
brain, and preliminary data suggest that 
the extent of these changes increased 
with the severity of the patients’ cogni­
tive impairment. 
Subsequent MRS studies have 
measured metabolites called choline­
containing compounds (Cho) and myo­
inositol (mIno), which reflect membrane-
related metabolic processes in glia cells. 
These studies also detected abnormalities 
in asymptomatic HIV-infected patients 
whose immune systems were still intact, 
with increased levels of Cho and mIno 
primarily in the white matter surrounding 
the ventricles and in the basal ganglia 
(see Navia and Gonzalez 1997). This 
finding is consistent with the neu­
ropathological studies demonstrating 
glial proliferation in those brain areas. 
Furthermore, greater increases in Cho 
and mIno levels were found in patients 
with more advanced dementia, higher 
levels of HIV in the cerebrospinal fluid 
(but not in the blood), and greater reduc­
tions in the number of CD4+ cells. 
Therefore, investigators have suggested 
that Cho and mIno measures may serve 
as markers of HIV-induced neuropatho­
logical changes or of CNS involvement. 
MRS technology also may help clin­
icians monitor the effects of antiretroviral 
Autopsy studies have shown that the 
brains of chronic alcoholics are smaller, 
lighter, and exhibit greater atrophy than 
those of nonalcoholics of the same age 
and gender (for a review, see Kril and 
Halliday 1999). This reduced brain size 
resulted primarily from white matter 
loss, especially in the frontal lobe. The 
extent of that white matter loss increased 
proportionally with the drinker’s maxi-
mum daily alcohol consumption. 
Overall, pathological studies revealed 
two kinds of alcohol-related damage to 
the cortex: loss of neurons primarily 
from the frontal cortex and widespread 
shrinkage of the neurons (i.e., reduced 
size of axons and dendrites) throughout 
the brain. Neuron loss is thought to be 
permanent whereas the size reduction 
of neurons and their dendrites is poten­
tially reversible with abstinence. In 
addition to this cortical damage, severe 
alcoholics also show reduced size and 
other abnormalities in various subcorti­
cal structures (e.g., the mammillary 
bodies and thalamus) and in a part of 
the cerebellum. Most of these findings 
have been confirmed in animals that were 
given alcohol in their drinking water 
over a long period, mimicking lifelong 
chronic alcohol abuse in humans. 
Scientists also had hypothesized that 
chronic alcohol abusers, who frequently 
exhibit memory loss and learning diffi­
culties, would show damage to the hip­
pocampus, a brain area associated with 
memory and learning. However, neu­
ropathological studies detected no sig­
nificant hippocampal neuron loss in 
alcoholics; instead, dendrites or meta­
bolism in the hippocampus of alco­
holics may be damaged (see Kril and 
Halliday 1999). 
The cerebral cortex is the seat of 
higher intellectual functions. Consistent 
with the findings of autopsy studies 
of chronic alcoholics demonstrating 
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The brains of 
chronic alcoholics are 
smaller, lighter, and 
exhibit greater 
atrophy than those 
of nonalcoholics of the 
same age and gender. 
Like magnetic resonance imaging (MRI), magnetic 
resonance spectroscopy (MRS) uses radio waves and a 
strong magnetic field to measure the concentration of 
naturally occurring metabolic byproducts called 
metabolites in the human body. This technique causes 
certain atoms in those metabolites to emit a signal that 
can be converted into an image, offering researchers a 
snapshot of the cellular activity taking place within the 
tissue studied. MRI measures the signals emitted by 
hydrogen atoms, found primarily in water and fat 
molecules (i.e., lipids). MRS, in contrast, detects signals 
emitted by other atoms (i.e., protons and phosphorus 
atoms), which typically are contained in molecules 
involved in energy metabolism and other vital cell 
functions and cell components (e.g., the cell membranes). 
As a result, MRS is thought to be more specific in measur­
ing tissue damage than MRI. Several metabolites exist that 
are relevant to HIV and alcohol research and that can be 
detected by proton and phosphorus MRS of the brain. 
Metabolites detectable by proton MRS include the 
following: 
• N-acetyl-aspartate (NAA). This protein building block 
(i.e., amino acid) is found almost exclusively in mature 
nerve cells (i.e., neurons) and is therefore considered a 
marker of neuronal viability. In the brain’s gray matter, 
NAA reflects the viability of neuronal cell bodies 
whereas in white matter it reflects the viability of the 
neuronal extensions that transmit nerve signals to 
other neurons (i.e., the axons). The exact function of 
NAA in the brain is largely unknown but it is thought 
to play a role in fat generation and fluid balance. 
• Creatine (Cr) and phosphocreatine (PCr). These com­
pounds allow the cell to store energy (by converting 
Cr into PCr) and to release that energy quickly when 
needed (by converting PCr back into Cr and inorganic 
phosphate, Pi). Therefore, these molecules reflect cellular 
energy metabolism in the tissues. PCr and Pi also can 
be measured using phosphorus MRS. 
• Choline-containing compounds (Cho). These molecules 
include several compounds that are building blocks 
and breakdown products of the membrane surrounding 
each cell. The primary components of these membranes 
are phosphorus-containing fat molecules (i.e., phospho-
lipids) Accordingly, Cho reflect various membrane-
related metabolic processes, including the generation 
and breakdown (i.e., turnover) of phospholipids (and, 
therefore, the membrane) and membrane integrity. In 
addition, Cho serves as an indicator of inflammation 
and gliosis—the excessive multiplication of glial cells, 
which provide a support function to the neurons. 
• Myo-inositol (mIno). This sugar molecule is believed 
to be characteristic for glial cells; its concentration is 
increased in gliosis and with membrane breakdown. 
Metabolites detectable by phosphorus MRS include the 
following: 
• Adenosinetriphosphate (ATP). This molecule is used 
for long-term energy storage in the cell and therefore 
provides a good indicator of energy metabolism. 
• Inorganic phosphate (Pi). This is a small phosphorus-
containing molecule that is crucial for the formation 
of cellular compounds involved in energy metabolism 
(i.e., ATP and PCr). Its concentration increases when 
the cell uses energy. 
• Phosphodiesters (PDE). This group of molecules consists 
of several breakdown products of membrane phos­
pholipid components, such as glycerophosphocholine, 
glycerophosphoethanolamine, and glycerophospho­
inositol. 
• Phosphomonoesters (PME). These molecules include 
building blocks for phospholipids, such as phospho­
choline and phosphoethanolamine. PDE and PME 
together are measures of membrane turnover and 
therefore complement Cho measures from proton 
MRS, providing another indicator of neuron function 
and integrity. 
• “Broad component” (BC). This composite signal, 
which can be measured at a specific static magnetic 
field strength, results from certain phospholipids 
within cell membranes. It is possibly a measure of 
membrane integrity. 
Instead of reporting absolute signal intensity or con­
centrations of the metabolites, researchers often measure 
the ratios between two of these metabolites for experimental 
reasons. Commonly used ratios include the NAA/Cr and 
NAA/Cho ratios. The interpretation of metabolite ratios, 
however, is sometimes ambiguous, because it may not be 
clear whether changes in the metabolite in the numerator, 
denominator, or both cause a change in the ratio. 
Despite such limitations, however, measurements of the 
levels of certain metabolites or their ratios can provide 
researchers with a picture of the health and function of 
cells within a living organism as well as of the effects that 
other substances, such as alcohol, have on the function and 
viability of those cells. 
—Dieter J. Meyerhoff 
Introduction to Magnetic Resonance Spectroscopy 
294 Alcohol Research & Health 
Alcohol and HIV Infection 
widespread cortical damage, neuropsy­
chological studies frequently have 
demonstrated cognitive deficits in this 
population (Oscar-Berman 2000). 
These include deficits in problem solving, 
organizing, planning, and abstraction 
(so-called executive functions that are 
associated with the frontal lobe); short-
term and long-term memory; verbal 
fluency; learning; and visuospatial per­
ceptions, which generally are associated 
with subcortical brain structures. 
Furthermore, the observed cerebellar 
shrinkage has been associated with 
impaired coordination and balance 
commonly found in alcoholics. Taken 
together, neuropathological and neuro­
psychological studies suggest that the 
frontal lobes are particularly susceptible 
to the deleterious effects of chronic 
alcohol use in humans but that other 
structures also are involved. 
Brain Structure and Metabolites 
in Chronic Alcohol Abusers 
Consistent with the neuropathological 
studies, imaging studies using computed 
tomography (CT) scans demonstrated 
atrophy in various brain regions of 
alcoholics as indicated by shrinkage of 
the cerebellum and widening of the 
ventricles and fluid-filled gaps (i.e., sulci) 
in the brain’s cortex, particularly in the 
frontal lobe (for reviews see Rosenbloom 
et al. 1995; Sullivan 2000). MRI stud­
ies also demonstrated volume loss in 
brain regions that show neuron loss in 
pathological studies, primarily in corti­
cal gray matter regions of the frontal 
lobes, but also in gray matter of the 
parietal and temporal lobes. This gray 
matter loss often is accompanied by 
increases in fluid volume in the same 
regions. In addition, MRI studies of 
chronic alcoholics have demonstrated 
white matter loss in the frontal-parietal 
brain and corpus callosum, as well as 
volume loss of subcortical structures 
(e.g., the thalamus, hypothalamus, and 
caudate) and the cerebellum. As did 
neuropathological studies, neuroimaging 
studies found no decrease in the size of 
the hippocampus, despite the memory 
and learning deficits observed in alco­
holics. Researchers have demonstrated 
some relationships between volume 
deficits in some brain areas and measures 
of neuropsychological impairment; 
however, these relationships have not 
been consistent. 
An alcoholic’s age influences how 
severe alcohol-related changes in brain 
structure and function are, with more 
severe and persistent alcohol-related 
changes evident in the brains of older 
alcoholics (Sullivan 2000). Age also 
appears to affect the brain’s ability to 
recover from alcohol-related damage. 
When alcoholics stop drinking, some 
of the gray and white matter loss and 
cognitive impairment caused by 
chronic drinking is reversible. Studies 
found that the recovery of brain struc­
ture and function is greater and more 
rapid in younger abstinent alcoholics 
than in older abstinent alcoholics (see 
Sullivan 2000). The significance of the 
recovery of brain structures for the 
recovery of brain functions is under 
active investigation. 
Despite their potential usefulness, 
MRS studies on the effects of chronic 
alcohol abuse on the brains of humans 
or animals are scarce (see Sullivan 2000). 
Studies of abstinent alcoholics generally 
suggest lower NAA levels in white mat­
ter regions of the frontal and parietal 
lobes as well as in the cerebellum and 
thalamus, consistent with neuronal 
and/or axonal damage in those regions 
that was not reversible by short-term 
abstinence. These observations support 
those of the neuropathological and 
neuropsychological studies described 
in the previous section. Patients with 
alcoholic dementia also reveal evidence 
of neuronal damage in the basal ganglia 
and occipital lobe. One MRS study 
compared certain brain metabolites 
in the thalamus and frontal cortical 
regions between alcoholics who had 
been abstinent for 1 month and alco­
holics who had been abstinent for 6 
years (see Sullivan 2000). The study 
found elevated mIno levels after short-
term abstinence but not after long-
term abstinence, suggesting that some 
alcohol-induced changes are reversible 
with prolonged abstinence. 
Comparison of the Brain Regions 
Affected by HIV Infection and 
Chronic Alcohol Abuse 
Taken together, the pathological, neuro­
psychological, structural, and metabolic 
evidence suggests that chronic alcohol 
abuse predominantly affects the frontal 
lobe whereas HIV—at least early in the 
course of the disease—primarily affects 
white matter deep within the brain as 
well as subcortical brain structures (see 
table). Cortical brain regions become 
involved only during advanced stages 
of HIV disease, which are associated 
with cognitive and some clinical impair­
ment. Furthermore, this cortical dam-
age may be delayed by HAART therapy. 
Based on these findings, the brain 
regions expected to be primarily affected 
in alcohol-abusing HIV-infected subjects 
include central white matter, subcortical 
brain structures, and the frontal cortex. 
These regions are the focus of current 
structural and metabolic MR studies of 
the combined effects of alcohol abuse 
and HIV infection on the brain. 
CNS Effects of Combined 
HIV Infection and Chronic 
Alcohol Abuse 
The findings reviewed so far strongly 
suggest that chronic alcohol abuse can 
adversely affect the natural course of 
HIV disease. To prove, however, that 
chronic alcohol abuse exacerbates the 
CNS effects of HIV infection, researchers 
must compare alcohol-abusing and 
nonalcohol-abusing HIV-infected patients 
on a variety of CNS measures. This 
section summarizes studies analyzing 
the interactive effects of HIV infection 
and chronic alcohol abuse on the brains 
of patients not treated with HAART. 
Using MRS of the brain, Meyerhoff 
and colleagues (1995) examined both 
HIV-positive and HIV-negative subjects 
who were either heavy drinkers (i.e., con­
sumed a mean of 228 drinks per month 
for at least 3 years prior to study) or light 
drinkers (i.e., consumed a mean of 14 
drinks per month over their lifetime). 
The light-drinking and heavy-drinking 
HIV-positive groups were matched for 
the degree to which their immune 
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systems were already impaired by the 
HIV infection, and both groups exhibited 
mild-to-moderate neuropsychological 
impairment. The study assessed the 
levels of two molecules called PCr and 
ATP, which reflect the cell’s energy 
metabolism, as well as of a group of 
compounds called PDE, which repre­
sent breakdown products of molecules 
found in the cell membranes. 
The study found that chronic alco­
hol consumption was associated with 
lower concentrations of PDE, PCr, and 
ATP in white matter of the region sur­
rounding the ventricles (i.e., the cen­
trum semiovale). Similarly, patients with 
advanced HIV disease or full-blown 
AIDS had lower levels of PDE, PCr, 
and ATP in the white matter compared 
with both HIV-negative subjects and 
clinically asymptomatic HIV-positive 
subjects. The metabolic effects of 
advanced HIV infection and alcohol 
abuse were cumulative, because HIV-
positive heavy drinkers clearly showed 
the greatest metabolic deficits in white 
matter. PDE levels also were significantly 
lower in subcortical gray matter, which 
is associated with learning and memory 
functions, of heavy drinkers with advanced 
HIV disease compared with HIV-
negative light drinkers. These findings 
are consistent with the neuropathological 
and neuropsychological observations 
demonstrating subcortical damage. 
Taken together, these findings suggest 
that both alcohol abuse and HIV infec­
tion alter the brain’s energy metabolism 
and the metabolism of cell membranes 
and that these alterations are associated 
with the presence of clinical HIV symp­
toms. More importantly, the study found 
that chronic alcohol abuse augmented 
the adverse effects of HIV on biologically 
important white matter molecules. 
Meyerhoff and colleagues (1997) 
also conducted a MRS study assessing 
different molecules, including NAA, in 
a similar patient population. That study 
found metabolic changes in the regions 
of the brain stem—a region at the base 
of the brain that performs motor, sensory, 
and reflex functions—of active heavy 
drinkers. These changes were consis­
tent with pathological evidence for the 
loss of certain neurons and for gliosis 
found throughout the brain stem of 
Brain Regions Affected by HIV Infection and Chronic Alcohol Abuse Based on 
Pathological, Psychological, Structural, and Metabolic Analyses 
Affected by Affected by 
Brain Region HIV Infection Alcohol Abuse 
Cortical gray matter + ++ 
Frontal lobe + ++ 
Parietal lobe + ++ 
Temporal lobe ? + 
White matter ++ ++ 
Periventricular ++ ++ 
Supraventricular ++ ++ 
Subcortical ? ++ 
Subcortical gray matter ++ ++ 
Basal ganglia ++ ++ 
Thalamus + + 
Hippocampus ? + 
Cerebellum ? ++ 
Brainstem (midbrain) ? + 
NOTE: ? = no evidence or unknown; + = some evidence; ++ = strong evidence 
chronic alcoholics. These changes were 
particularly pronounced in HIV-positive 
heavy drinkers, suggesting that HIV 
infection may have an additional adverse 
effect on brain stem metabolites. 
These studies, which were performed 
before the introduction of HAART ther­
apy, suggest that chronic alcohol abuse 
exacerbates some metabolic injury in 
the HIV-infected brain. Electrophysio­
logical studies, which measure certain 
aspects of the brain’s electrical activity, 
have provided additional evidence for 
an additive effect of heavy drinking on 
brain damage in HIV-infected subjects. 
One study assessed an electric signal 
measurable in the frontal lobe that is 
thought to reflect mental processes 
requiring attention and memory updating 
(Fein et al. 1998). This signal is delayed 
in HIV-infected subjects, but the delays 
occurred earlier in the course of HIV 
disease in alcohol-abusing than in light-
drinking or abstinent HIV-infected sub­
jects. Researchers are currently investi­
gating the cognitive and behavioral 
significance of these brain changes. 
The effect of modern antiretroviral 
treatment (i.e., HAART therapy) on 
the specific brain alterations observed 
in alcohol-abusing HIV-positive patients 
has not yet been investigated thoroughly. 
Very preliminary data from MRI and 
MRS studies on light- and heavy-
drinking HIV-negative and HIV-positive 
subjects (with most of the HIV-positive 
subjects on HAART therapy) detected 
some of the brain injury commonly 
associated with HIV infection and with 
alcohol abuse. The studies found little 
evidence, however, that chronic alcohol 
abuse exacerbated the CNS effects of 
HIV infection in these treated patients. 
Future Outlook 
Researchers have begun to investigate 
the effects of chronic alcohol abuse on 
HIV-associated CNS disease, integrat­
ing studies of immunology, neuropsy­
chology, behavior, and drug-availability 
(i.e., potential interactions between HIV 
medications and alcohol) in the body 
with studies of brain electrophysiology, 
structure, and function. Longitudinal 
studies, which follow a group of sub­
jects over extended periods of time, will 
allow a more powerful assessment of 
the CNS effects of combined chronic 
alcohol abuse and HIV disease. Such 
studies may help answer the question 
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whether aggressive alcoholism treatment viral treatments may not only acceler- tected sex or needle sharing) in HIV-
can help ameliorate the functional and ate disease progression in individual infected people, although a discussion 
behavioral consequences of the brain patients but, perhaps more importantly, of this issue is beyond the scope of this 
injury associated with HIV disease. may undermine therapeutic control of article. If such associations exist, how-
This research also can provide impor- the HIV epidemic by allowing drug- ever, they could make chronic heavy 
tant information on whether and how resistant HIV strains to emerge in drinking in HIV-positive people a par-

chronic heavy drinking compromises patients who take insufficient doses of ticularly potent risk factor for the fur-

the effectiveness of emerging antiretro- their medications.7 Current research ther spread of HIV. ■

viral therapies, either through behavioral also will provide important data on the

effects on treatment seeking and treat- association of heavy alcohol use with References
ment adherence or through biological continued risk behavior (e.g., unpro­

effects on the metabolism and levels of BAGASRA, O.; KAJDACSY-BALLA, A.; LISCHNER, H.W.;

antiretroviral medications. Such poten- 7The experience with tuberculosis offers a precedent for AND POMERANTZ, R.J. Alcohol intake increases human

tial effects on the efficacy of antiretro- such concerns. immunodeficiency virus type 1 replication in human

G L O S S A R Y

Antiretroviral therapy: Treatment to combat infection with 
HIV, which belongs to a class of viruses called retrovirus. 
Astrocyte: A star-shaped type of glial cell that provides structural 
and functional support to surrounding neurons and is 
important for the regulation of ion concentrations. 
Axon: A large fiber extending from the cell body of a neuron 
that conducts nerve signals to other neurons. 
Basal ganglia: Groups of neurons located deep within the brain 
that help control motor and cognitive activity. 
CD4+ cell: An immune cell (i.e., lymphocyte) found in the 
blood that performs important regulatory immune func­
tions, thereby protecting the organism against infections; 
also called T-helper cell. 
Cerebellum: A structure at the base of the brain that is involved 
in the control of muscle tone, balance, and sensorimotor 
coordination. 
Cerebral cortex: The outer, intricately folded layer of gray matter 
covering the cerebrum; contains areas for processing sensory 
information, controlling motor functions, speech, higher 
cognitive functions, emotions, behavior, and memory. 
Cerebrospinal fluid: The fluid that surrounds and fills the 
spaces in the brain and spinal cord. 
Cerebrum: The largest portion of the brain; consists of two 
cerebral hemispheres. 
Corpus callosum: A tract of nerve fibers connecting the two 
hemispheres of the cerebrum. 
Cytokine: A compound that acts as a chemical messenger 
between cells in the immune system and other immune and 
nonimmune cells; if their levels are not controlled tightly, 
cytokines can damage or kill neurons. 
Dendrite: A branched projection extending from the body of a 
neuron that relays electric signals from other neurons to the 
cell body. 
Glial cells: Brain cells that provide support functions for the 
neurons. 
Gliosis: Excessive multiplication of glial cells. 
Gray matter: Brain tissue consisting mostly of neuronal cell 
bodies and dendrites; constitutes the outer, extensively 
folded layer of the brain. 
Highly active antiretroviral therapy (HAART): Treatment 
regimen for HIV infection consisting of three medications 
from different classes of medications that target important 
viral enzymes; must be taken according to a strict schedule 
to be most effective. 
Ion: An electrically charged atom or group of atoms. 
Metabolism: The processes related to the production and 
breakdown of all types of molecules in the body, whether 
they serve as structural components of the cells or to provide 
energy for the body and each cell. 
Microglia: A type of glial cell that can turn into a type of 
immune cell called a phagocyte or macrophage; can be 
infected by HIV. 
Neuron: A nerve cell; consists of cell body, dendrites, and axon. 
Oligodendrocyte: A type of glial cell that forms long extensions 
containing a protein called myelin; these extensions wrap 
themselves around axons to form a protective sheath. 
Opportunistic infection: An infection that can normally be 
controlled by an intact immune system but that causes ill­
ness in a person with a damaged immune system. 
Phagocyte: A type of immune cell that seeks out and destroys 
foreign microorganisms, viruses, and dead cells; also called 
macrophage. 
Subcortical: Located deep inside the brain below the cerebral cortex. 
Sulci (sulcus): The grooves on the surface of the brain, filled 
with cerebrospinal fluid. 
Thalamus: A gray-matter structure deep inside the brain that 
forms the brain’s relay center to the cerebral cortex. 
Ventricles: Fluid-filled spaces between the brain’s hemispheres 
or in other organs (e.g., the heart). 
White matter: Brain tissue consisting mostly of glial cells; axons; 
and myelin, a protective lipid layer surrounding the axons. 
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